A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1.

[1]  G. Carpenter,et al.  ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression* , 2006, Journal of Biological Chemistry.

[2]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[3]  M. Seno,et al.  Betacellulin-δ4, a Novel Differentiation Factor for Pancreatic β-Cells, Ameliorates Glucose Intolerance in Streptozotocin-Treated Rats , 2005 .

[4]  Samuel Bouyain,et al.  The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Seno,et al.  Differentiation of Adult Hepatic Stem-Like Cells into Pancreatic Endocrine Cells , 2005, Cell transplantation.

[6]  Akihiko Kondo,et al.  The specific delivery of proteins to human liver cells by engineered bio‐nanocapsules , 2005, The FEBS journal.

[7]  P. Dempsey,et al.  ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx* , 2005, Journal of Biological Chemistry.

[8]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Wells,et al.  DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. , 2004, Experimental cell research.

[10]  Zhaohong Yi,et al.  Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. , 2004, Diabetes.

[11]  A. Mammoto,et al.  Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF , 2003, The Journal of cell biology.

[12]  M. Seno,et al.  Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor cells to beta-cells in streptozotocin-treated mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[13]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[14]  M. Fujimiya,et al.  NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice , 2003, Nature Medicine.

[15]  G. Carpenter,et al.  ErbB-4: mechanism of action and biology. , 2003, Experimental cell research.

[16]  A. M. Stanley,et al.  Structure of the extracellular region of HER 2 alone and in complex with the Herceptin Fab , 2022 .

[17]  Edouard C. Nice,et al.  Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.

[18]  Jae-Hoon Kim,et al.  Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.

[19]  Hyun-soo Cho,et al.  Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether , 2002, Science.

[20]  M. Seno,et al.  Solution structure of betacellulin, a new member of EGF-family ligands. , 2002, Biochemical and biophysical research communications.

[21]  M. Seno,et al.  Promotion of β-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats. , 2001, Endocrinology.

[22]  O. Nishimura,et al.  Novel Betacellulin Derivatives , 2001, The Journal of Biological Chemistry.

[23]  C. Goddard,et al.  Identification of an Alternatively Spliced mRNA Transcript of Human Betacellulin Lacking the C-Loop of the EGF Motif and the Transmembrane Domain , 2000, Growth factors.

[24]  M. Sliwkowski,et al.  Binding specificities and affinities of egf domains for ErbB receptors , 1999, FEBS letters.

[25]  M. Sliwkowski,et al.  Binding Interaction of the Heregulinβ egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis* , 1998, The Journal of Biological Chemistry.

[26]  M. Kanzaki,et al.  Studies on the betacellulin receptor in pancreatic AR42J cells , 1998, Diabetologia.

[27]  I. Lax,et al.  Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. , 1997, Journal of biochemistry.

[28]  J. McCafferty,et al.  Antibody engineering: a practical approach , 1997 .

[29]  T. Hanafusa,et al.  Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. , 1996, The Journal of clinical investigation.

[30]  A. Ashkenazi,et al.  Immunoadhesins: principles and applications. , 1996, Trends in biotechnology.

[31]  T. van Raaij,et al.  Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. , 1996, Oncogene.

[32]  T. Watanabe,et al.  Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction. , 1994, The Journal of biological chemistry.

[33]  H. Scheraga,et al.  Solution structure of human type-alpha transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints. , 1993, Biochemistry.

[34]  D. Hanahan,et al.  Betacellulin: a mitogen from pancreatic beta cell tumors. , 1993, Science.

[35]  D. Tadaki,et al.  Evaluation of the role of electrostatic residues in human epidermal growth factor by site‐directed mutagenesis and chemical modification , 1992, Journal of cellular biochemistry.

[36]  G. Sathe,et al.  Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis. , 1992, Biochemical Journal.

[37]  S. Kuroda,et al.  Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. , 1992, The Journal of biological chemistry.

[38]  D. Engler,et al.  Cloning of authentic human epidermal growth factor as a bacterial secretory protein and its initial structure-function analysis by site-directed mutagenesis. , 1988, The Journal of biological chemistry.

[39]  M. Koyama,et al.  An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.

[40]  J. Folkman,et al.  Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. , 1996, Growth factors.